Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,447
Total Claims
$3.0M
Drug Cost
974
Beneficiaries
$3,036
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+322%
Cost per patient vs peers
$3,036 vs $719 avg
+145%
Brand preference vs peers
16.3% vs 6.7% avg
Brand vs Generic
Brand: 2,174 claims · $2.5M
Generic: 11,184 claims · $453K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 453 | $573K |
| Tirzepatide | 161 | $234K |
| Budesonide/Glycopyr/Formoterol | 218 | $225K |
| Linaclotide | 98 | $124K |
| Empagliflozin | 79 | $122K |
| Sitagliptin Phosphate | 79 | $106K |
| Semaglutide | 49 | $96K |
| Dulaglutide | 61 | $94K |
| Dapagliflozin Propanediol | 51 | $69K |
| Mirabegron | 59 | $65K |
| Linagliptin | 43 | $51K |
| Empaglifloz/Linaglip/Metformin | 31 | $49K |
| Denosumab | 28 | $48K |
| Rivaroxaban | 32 | $42K |
| Apixaban | 31 | $40K |
Prescribing Profile
Patient Profile
72
Avg Age
61%
Female
1.69
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data